Baricitinib, Methotrexate, or Combination in Patients with Rheumatoid Arthritis and no or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Arthritis Rheumatol 2016. DOI 10.1002/art.39953. Accepted article
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Rheumatol 2016. DOI 10.1002/art.39953. Accepted article
Arthritis Res Ther 2016; 18:198. DOI.10.1186/s13075-016-9
Arthritis Care Res 2016; Accepted article. DOI 10.1002/acr.23004
Arthritis Care Res 2016; Accepted article. DOI 10.1002/acr.23008.
Arthritis Rheumatol 2016; Accepted article DOI 10.1002/art-39808 [Epub 2016]
Arthritis Research & Therapy. 2016. DOI 10.1186/s13075-016-1049-3 [Epub ahead of print]
Clin Ther. 2016 Mar 28. doi: 10.1116/j.clinthera. 2016.03.038 [Epub ahead of print]
N Engl J Med. 2016 Mar 31;374(13):1243-52. doi: 10.1056/NEJMoa1507247
Strand et al. Rheumatology (Oxford). 2016 Feb 29. doi:pii: kev442. [Epub ahead of print]
Arthritis Research & Therapy (2015) 17:307 DOI: 10.1186/s13075-015-0825-9 [Epub ahead of print]